HCV combination therapy comprising pegylated interferon, ribavirin and telaprevir
展开▼
机译:包含聚乙二醇化干扰素,利巴韦林和特拉普韦的HCV联合疗法
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention relates to combination therapies for the treatment of hepatitis C virus with telaprevir and pegylated interferon alfa-2a with or without ribavirin. The invention relates to the treatment of patients with bridging fibrosis infected with HCV using the combination therapy.
展开▼